Millie
your market intelligence analyst
Search Results
33 results
Your search is now limited to «Celgene» expert search.
FierceBiotech 09/22/2020 10:28
Bristol Myers Squibb may have bounced Jounce Therapeutics from its roster of inherited partners, but it’s hanging onto Anokion, an autoimmune disease biotech Celgene teamed up with in 2016.
More from FierceBiotech:
Business Wire 09/17/2020 08:03
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as "Dr. Reddy’s"), today announced the settlement of their litigation with Celgene, a wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY), relating to patents for REVLIMID® (lenalidomide) Capsules.
ENDPOINTS 09/17/2020 07:21
After leading Celgene buyout, Matthew Roden leaves Bristol Myers Squibb for venture capital firm – Endpoints News.
More from ENDPOINTS:
Updated Date: Mon, 14 Sep 2020 00:00:00 EDT.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
PharmiWeb.com 08/12/2020 02:46
Pune, Maharashtra, India, August 12 2020 (Wiredrelease) MarketResearch.Biz –: The recent report posted via MarketResearch.Biz on Lymphoma market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market. Global Lymphoma Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements controlling the advan...
More from PharmiWeb.com:
Daily Excelsior (India) 07/10/2020 14:59
NEW DELHI, July 10: Natco Pharma on Friday said its Canadian subsidiary has entered into a settlement agreement with biopharmaceutical firm Celgene (part of Bristol-Myers Squibb) for Lenalidomide capsules. Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. “Natco Pharma (Canada) Inc., Canada, a […]. .

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications